HSV Strains Recombining, Potentially Impacting Vaccine Development HSV Strains Recombining, Potentially Impacting Vaccine Development

Herpes simplex viruses 1 and 2 (HSV-1 and HSV-2) are recombining, suggesting that live attenuated HSV-2 vaccine candidates carry a"significant risk" of recombining with circulating HSV-1 strains to form an infectious virus, researchers say.Reuters Health Information

Source: Medscape Medical News Headlines - May 13, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news